Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3753)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 28, 2023 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahn HM, Kim DW, Oh HJ, Kim HK, Lee HS, Lee TG, Shin HR, Yang IJ, Lee J, Suh JW, Oh HK, Kang SB. Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value. World J Gastroenterol 2023; 29(32): 4883-4899 [PMID: 37701134 DOI: 10.3748/wjg.v29.i32.4883] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i32/4883.htm |
| Number | Citing Articles |
| 1 |
José Luis Venegas-Rodríguez, Jesús Arturo Hernández-Sandoval, Melva Gutiérrez-Angulo, José Miguel Moreno-Ortiz, Anahí González-Mercado, Jorge Peregrina-Sandoval, Helen Haydee Fernanda Ramírez-Plascencia, Beatriz Armida Flores-López, Carlos Rogelio Alvizo-Rodríguez, Jesús Alonso Valenzuela-Pérez, Sergio Cervantes-Ortiz, María de la Luz Ayala-Madrigal. KRAS Exon 2 Mutations in Patients with Sporadic Colorectal Cancer: Prevalence Variations in Mexican and Latin American Populations. Cancers 2024; 16(13): 2323 doi: 10.3390/cancers16132323
|
| 2 |
Zhiyan Jiang, Yan Li, Xin Zhou, Jie Wen, Pengwu Zheng, Wufu Zhu. Research progress on small molecule inhibitors targeting KRAS G12C with acrylamide structure and the strategies for solving KRAS inhibitor resistance. Bioorganic & Medicinal Chemistry 2024; 100: 117627 doi: 10.1016/j.bmc.2024.117627
|
| 3 |
Pieterjan Vanclooster, Sofie Seghers, Hans Prenen. State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies. Current Opinion in Oncology 2024; 36(4): 313 doi: 10.1097/CCO.0000000000001042
|